For Immediate Release:
February 20, 2014
Pittsfield, MA – Nuclea Biotechnologies, Inc. recently announced that Immuno-Biological Laboratories Inc., (IBL-America) would be their primary US distributor for the serum HER-2/neu kits. IBL-America, based in Minneapolis, MN, is a distributor of high quality diagnostic assays in various areas including autoimmunity, endocrinology, infectious disease, oncology, and neuroscience and offers technical laboratory services as well.
Nuclea is a specialist in serum based oncoprotein diagnostics and offers tests for In Vitro Diagnostic (IVD) and Research Use Only (RUO). Nuclea provides the only FDA-cleared through 510(k) IVD ELISA test for the measurement of serum HER-2/neu in the management and monitoring of women with metastatic breast cancer. This microtiter based test enables laboratories to measure the level of HER-2/neu in serum in a cost-efficient and validated manner. This test is reimbursed by insurance companies and has a unique CPT code 83950.
Additionally, the two companies will coordinate joint marketing efforts for the serum HER-2/neu kits.
“As we continue to see the market respond to our serum HER-2/neu test, we’ve been securing partners who have strong distribution channels,” said Patrick Muraca, President and CEO of Nuclea. “IBL-America has a proven track record and I’m excited to have them as a partner.”
Mark Kowal, President and CEO of IBL-America stated “We, at IBL-America, are excited about the opportunity to work with the professionals at Nuclea. The HER-2/neu test is an excellent addition to our line of oncology products and we welcome this promising joint venture.”
Nuclea Biotechnologies, Inc. -- is headquartered in Pittsfield, Massachusetts with additional operations in Worcester and Cambridge, Massachusetts. Nuclea has developed and is commercializing unique diagnostic tests for colon, breast, leukemia, lung and prostate cancer. Nuclea also performs research leading to novel molecular oncology companion diagnostics for the pharmaceutical and biotechnology industries. http://www.nucleabio.com
IBL-America - IBL-America is a privately owned US corporation located in Minneapolis, MN, and since 1997 has been an established provider of in-vitro diagnostic assays to major US laboratories and hospitals. With annual sales of $4MM+ IBL-America continues to provide the diagnostic community with the products and technical service required to meet today’s high quality standards and regulations. Additionally IBL-America supplies research assays as well as antibodies and proteins to thousands of laboratories across North and South America. Through their sister company, KMI Diagnostics, Inc., IBL-America can also provide testing services for endocrinology and research projects. More information is available at www.ibl-america.com and www.kmidiagnostics.com.